|
|
|
|
Roche's ABPI exit - a deliberate snub?
Roche is yet to explain its controversial exit from the ABPI, but the company seems determined to make a point with its rebuff of the association.A spokesperson told Pharmafocus the pharma company remains committed to the self-regulatory...
|
|
|
Roche's ABPI exit - a deliberate snub?
Roche is yet to explain its controversial exit from the ABPI, but the company seems determined to make a point with its rebuff of the association.A spokesperson told Pharmafocus the pharma company remains committed to the self-regulatory...
|
|
|
Roche decides not to rejoin the ABPI, but will abide by its code
Roche has decided not to renew its membership of the Association of the British Pharmaceutical Industry but says it will continue to work within the associations code of practice.Roche was suspended from the ABPI in 2008 for six months...
|
|
|
Roche quits ABPI
Roche has chosen to end its membership of the ABPI in a surprise move that could undermine the UK's system of industry self-regulation.The company said it had 'decided not to re-join the ABPI for the time being' but said it would ...
|
|
|
Roche quits ABPI
Roche has chosen to end its membership of the ABPI in a surprise move that could undermine the UK's system of industry self-regulation.The company said it had 'decided not to re-join the ABPI for the time being' but said it would ...
|
|
|
Roche quits ABPI
Roche has chosen to end its membership of the ABPI in a surprise move that could undermine the UK's system of industry self-regulation.The company said it had 'decided not to re-join the ABPI for the time being' but said it would ...
|
|
|
Roche: Goodbye PhRMA and ABPI, hello BIO
Roche no longer wants to associate with the rest of Big Pharma.The Swiss company is pulling out of the U.S. pharmaceuticals association, PhRMA, and is resigning from PhRMA's opposite number in the U.K., the Association of the British...
|
|
|
29 Jun 09 | Roche UK Resigns from ABPI
According to an article in the Financial Times, Roche UK have decided not to renew their membership of the ABPI (Association of the British Pharmaceutical Industry).This follows the company being suspended last year for serious breaches...
|
|
|
Roche UK resigns from ABPI
3680 live jobs on PharmiWeb.com now According to an article in the Financial Times, Roche UK have decided not to renew their membership of the ABPI (Association of the British Pharmaceutical Industry).This follows the company being...
|
|
|
U.S. FDA releases list of potential drug risks
View of pills manufactured on a production line in a pharmaceutical company.regulators have listed two dozen drugs, including weight-loss medicines and sleep disorder pills, that it is at an early stage of reviewing for potential safety...
|
|
|
U.S. FDA releases list of potential drug risks
WASHINGTON (Reuters) - U.S.regulators on Thursday listed two dozen drugs, including weight-loss medicines and sleep disorder pills, that it is at an early stage of reviewing for potential safety problems. Many of the issues have been...
|
|
|
U.S. FDA releases list of potential drug risks
WASHINGTON (Reuters) - U.S.regulators on Thursday listed two dozen drugs, including weight-loss medicines and sleep disorder pills, that it is at an early stage of reviewing for potential safety problems. Many of the issues have been...
|
|
|
U.S. FDA releases list of potential drug risks
WASHINGTON (Reuters) - U.S.regulators on Thursday listed two dozen drugs, including weight-loss medicines and sleep disorder pills, that it is at an early stage of reviewing for potential safety problems. Many of the issues have been...
|
|
|
Chantix, Xenical still under FDA probe
FDA aired its quarterly laundry list of drug-safety probes yesterday, reminding us--and everyone else--of its ongoing investigations.Nineteen drugs made the list, several with multiple brand names. Some of those meds won't be on the...
|
|
|
FDA investigates weight loss drug Alli for liver damage
FDA is investigating the only over-the-counter weight loss drug Alli following signals that it could be linked to liver damage.Sold by drug giant GlaxoSmithKline (GSK), Alli was approved as the only non-prescription weight loss drug in...
|
|
|
FDA investigates weight loss drug for liver damage
Yesterday, FDA updated drug surveillance information on its website and added orlistat to the list of products that are identified as potentially harmful.Orlistat is a weight loss drug sold by drug giant GlaxoSmithKline (GSK) under the...
|
|
|
2nd UPDATE:FDA Evaluating Safety Of Weight Drugs Alli,Xenical
(Updates with Roche comment in 10th paragraph) By Jennifer Corbett Dooren Of DOW JONES NEWSWIRES WASHINGTON -(Dow Jones)- The Food and Drug Administration is conducting a safety review of weight-loss drugs Alli and Xenical and looking...
|
|
|
FDA releases list of potential drug risks
Reuters View of pills manufactured on a production line in a pharmaceutical company.REUTERS/Jacky Naegelen WASHINGTON (Reuters) U.S. regulators on Thursday listed two dozen drugs, including weight-loss medicines and sleep disorder pills...
|
|
|
FDA Releases List of Potential Drug Risks
regulators on Thursday listed two dozen drugs, including weight-loss medicines and sleep disorder pills, that it is at an early stage of reviewing for potential safety problems.Many of the issues have been previously disclosed, but remain...
|
|
|
FDA releases list of potential drug risks - Yahoo! News
WASHINGTON (Reuters) U.S.regulators on Thursday listed two dozen drugs, including weight-loss medicines and sleep disorder pills, that it is at an early stage of reviewing for potential safety problems. Many of the issues have been...
|
|
|
FDA Releases List Of Potential Drug Risks
regulators on Thursday listed two dozen drugs, including weight-loss medicines and sleep disorder pills, that it is at an early stage of reviewing for potential safety problems.Many of the issues have been previously disclosed, but remain...
|
|
|
UPDATE 4-U.S. FDA releases list of potential drug risks
By Lisa Richwine WASHINGTON, June 4 (Reuters) - U.S.regulators on Thursday listed two dozen drugs, including weight-loss medicines and sleep disorder pills, that it is at an early stage of reviewing for potential safety problems. Many...
|
|
|
UPDATE 3-U.S. FDA releases list of potential drug risks
By Lisa Richwine WASHINGTON, June 4 (Reuters) - U.S.regulators on Thursday listed two dozen drugs, including weight-loss medicines and sleep disorder pills, that it is at an early stage of reviewing for potential safety problems. Many...
|
|
|
UPDATE 2-US FDA releases list of potential drug risks
By Lisa Richwine WASHINGTON, June 4 (Reuters) - U.S.regulators on Thursday listed two dozen drugs, including weight-loss medicines and sleep disorder pills, that it is at an early stage of reviewing for potential safety problems. Many...
|
|
|
U.S. FDA releases list of potential drug risks
* FDA at early stage of safety reviews for the drugs * Drugs for weight loss, sleep disorders on list * List does not mean problems were caused by drug -- FDA WASHINGTON (Reuters) - U.S.regulators Thursday listed two dozen drugs,...
|
